Abstract
BackgroundEffective CD3 T-cell engagers (TCEs) must balance potency with potential toxicities, such as cytokine release syndrome. The CD3- and tumor-binding arms should function together to maximize tumor-cell killing while fine-tuning...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
